4.2 Article

Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy

Journal

DIGESTIVE DISEASES
Volume 34, Issue 1-2, Pages 112-121

Publisher

KARGER
DOI: 10.1159/000443014

Keywords

Crohn's disease; Ulcerative colitis; Concomitant antibiotic therapy; Intestinal dysbiosis

Ask authors/readers for more resources

The inflammatory bowel diseases, Crohn's and ulcerative colitis, have been treated with a range of antibiotics for inducing and maintaining remission, as well as the prevention of post-operative symptoms. To date, many studies have been performed assessing the efficacy of antibiotics when used alone, in combination with other antibiotics, or as an adjunctive therapy to other pharmaceutical treatments. Literature evidence supporting the use of antibiotics in IBD can be ambiguous, especially when considering the potential role of dysbiosis in the gastrointestinal tract. The review considers the systemic effect of antibiotics and the evidence base for their efficacy in the treatment of IBD. (C) 2016 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available